Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

The stock's fall snapped a four-day winning streak.

Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition costs. Learn more about LLY stock here.

Shares of Eli Lilly & Co. LLY advanced 1.61% to $725.22 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.05% to 5,921 ...

The S&P 500 climbed 0.13% to end the session at 5,282.70 points. The Nasdaq declined 0.13% to 16,286.45 points, while the Dow Jones Industrial Average declined 1.33% to 39,142.23 points.

Eli Lilly down 19% in May, worst month since 2009. Underperformed S&P 500 by 24%, worst since August 2000. June shows promise, historically Lilly’s strongest month. From tariffs to inflation ...

Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and ...

Concentration levels in the S&P 500 are at their highest levels since 1932. ... Eli Lilly: $770 billion; AAPL Total Return Level data by YCharts. With the exception of Berkshire and Lilly, ...

Shares of Eli Lilly jumped 16% Thursday morning to lead S&P 500 gainers after the pharmaceutical company released clinical trial results for its oral weight-loss drug that "demonstrated ...

The damage continues and about 80% of the S&P 500 companies were in red this week. ... Pharmaceutical company Eli Lilly is known as one of the best pharma plays to bet your money on. It is ...